Dynavax to Present at June 2024 Investor Conferences

7 June 2024

Dynavax Technologies Corporation, a biopharmaceutical company located in Emeryville, California, is set to participate in several investor conferences in June 2024. These events offer a platform for Dynavax to present its latest advancements and strategies to potential investors and stakeholders. The schedules for their presentations are as follows:

- On June 4, at 1:20 p.m. CT, Dynavax will present at the William Blair 44th Annual Growth Stock Conference.
- On June 10, at 4:00 p.m. ET, the company will present at the Goldman Sachs 45th Annual Global Healthcare Conference.

Both presentations will be accessible via webcast. Interested parties can view these through the "Events & Presentations" section on the company's website.

Dynavax is at the forefront of developing and commercializing vaccines designed to protect against infectious diseases. The company's portfolio includes two major commercial products. The first is HEPLISAV-B®, a Hepatitis B vaccine (Recombinant), Adjuvanted, which is approved in the U.S., the European Union, and Great Britain. This vaccine is designed to prevent infection from all known subtypes of the hepatitis B virus in adults aged 18 and older. The second product, CpG 1018® adjuvant, is an essential component in several adjuvanted COVID-19 vaccines.

The company is not only focusing on its current products but is also actively advancing CpG 1018 as a preferable vaccine adjuvant. Current clinical programs include vaccines for shingles and Tdap (Tetanus, Diphtheria, and Pertussis). Further, through various global collaborations, Dynavax is also targeting the development of adjuvanted vaccines for COVID-19, plague, seasonal influenza, and a universal influenza vaccine.

Dynavax's commitment to innovation in vaccine development continues to position the company as a significant player in the biopharmaceutical industry. 

How to obtain the latest research advancements in the field of biopharmaceuticals?

In the Synapse database, you can keep abreast of the latest research and development advances in drugs, targets, indications, organizations, etc., anywhere and anytime, on a daily or weekly basis. Click on the image below to embark on a brand new journey of drug discovery!